Picture of VIVA Biotech Holdings logo

1873 — VIVA Biotech Holdings Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapContrarian

Momentum

Relative Strength (%)
1m-4.35%
3m-5.91%
6m-4.86%
1yr-54.63%
Volume Change (%)
10d/3m-41.73%
Price vs... (%)
52w High-55.94%
50d MA-8.93%
200d MA-21.5%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital5.16%
Return on Equity4.53%
Operating Margin15.47%

Financial Summary

Year End 31st DecUnit202120222023202420252026E2027ECAGR / Avg
Total RevenueCNYm2,104.082,379.632,155.581,986.651,729.452,077,659.86n/a19.93%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/a+284.09+66.38n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202631st Dec 2027
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2026 / 2027

Blurred out image of VIVA Biotech Holdings EPS forecast chart

Profile Summary

VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.

Directors

Last Annual
December 31st, 2025
Last Interim
June 30th, 2026
Incorporated
August 27th, 2008
Public Since
May 9th, 2019
No. of Employees
2,213
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
hk flag iconStock Exchange of Hong Kong Limited
Shares in Issue
2,093,553,353

1873 Share Price Performance

Similar to 1873

Picture of 160 Health International logo

160 Health International

hk flag iconStock Exchange of Hong Kong Limited

Picture of 3D Medicines logo

3D Medicines

hk flag iconStock Exchange of Hong Kong Limited

Picture of 3SBio logo

3SBio

hk flag iconStock Exchange of Hong Kong Limited

Picture of Ab&B Bio-Tech JS logo

Ab&B Bio-Tech JS

hk flag iconStock Exchange of Hong Kong Limited

Picture of AIM Vaccine logo

AIM Vaccine

hk flag iconStock Exchange of Hong Kong Limited

FAQ